Antibiotics protect against septic shock in mice administered β-glucan and indomethacin

Microbiology and Immunology

Volumn 51, Issue 9, 2007, Pages 851-859

  Nameda, Sachiko ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Antibiotics; Enterobacteria; Indomethacin; Glucan

Indexed keywords

AMPICILLIN; BETA GLUCAN; CILASTATIN PLUS IMIPENEM; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SCHIZOPHYLLAN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; BODY WEIGHT; COLON FLORA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENTEROBACTERIACEAE; LEUKOCYTE ACTIVATION; LIVER INJURY; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; SURVIVAL;

ANIMALIA; ENTEROBACTERIACEAE; MUS;

EID: 34548822407     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03981.x     Document Type: Article

References (31)

1. Alexopoulou, L., and Kontoyiannis, D. 2005. Contribution of microbial-associated molecules in innate mucosal responses. Cell. Mol. Life Sci. 62: 1349-1358.
2. Balish, E., and Warner, T. 2002. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160: 2253-2257.
3. Basivireddy, J., Jacob, M., Pulimood, A.B., and Balasubramanian, K.A. 2004. Indomethacin-induced renal damage: role of oxygen free radicals. Biochem. Pharmacol. 67: 587-599.
4. Bing, R.J. 2003. Cyclooxygenase-2 inhibitors: is there an association with coronary or renal events? Curr. Atheroscler. Rep. 5: 114-117.
5. Brun-Buisson, C., Doyon, F., Carlet, J., Dellamonica, P., Gouin, F., Lepoutre, A., Mercier, J.C., Offenstadt, G., and Regnier, B. 1995. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU group for severe sepsis. JAMA 274: 968-974.
6. Ferraz, J.G., Sharkey, K.A., Reuter, B.K., Asfaha, S., Tigley, A.W., Brown, M.L., McKnight, W., and Wallace, J.L. 1997. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology 113: 195-204.
7. Gambaro, G., and Perazella, M.A. 2003. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J. Intern. Med. 253: 643-652.
8. Garcia-Tsao, G., and Wiest, R. 2004. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract. Res. Clin. Gastroenterol. 18: 353-372.
9. Gaudio, E., Taddei, G., Vetuschi, A., Sferra, R., Frieri, G., Ricciardi, G., and Caprilli, R. 1999. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44: 1458-1475.
10. Giovannucci, E., Egan, K.M., Hunter, D.J., Stampfer, M.J., Colditz, G.A., Willett, W.C., and Speizer, F.E. 1995. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333: 609-614.
11. Guarner, F., and Malagelada, J.R. 2003. Gut flora in health and disease. Lancet 361: 512-519.
12. Gullo, A., Iscra, F., Di Capua, G., Berlot, G., Lucangelo, U., Chierego, M.L., Ristagno, G., Peratoner, A., Fasiolo, S., Consales, C., De Martino, G., and Tufano, R. 2005. Sepsis and organ dysfunction: an ongoing challenge. Minerva. Anestesiol. 71: 671-699.
13. Halliday, G., Robinson, S.R., Shepherd, C., and Kril, J. 2000. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27: 1-8.
14. Lepper, P.M., Held, T.K., Schneider, E.M., Bolke, E., Gerlach, H., and Trautmann, M. 2002. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med. 28: 824-833.
15. Lissac, J., and Kayal, S. 1995. Recent data on the physiopathology of septic shock. Bull. Acad. Natl. Med. 179: 1671-1688.
16. Loher, F., Bauer, C., Landauer, N., Schmall, K, Siegmund, B., Lehr, H.A., Dauer, M., Schoenharting, M., Endres, S., and Eigler, A. 2004. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J. Pharmacol. Exp. Ther. 308: 583-590.
17. Marshall, J.C., Cook, D.J., Christou, N.V., Bernard, G.R., Sprung, C.L., and Sibbald, W.J. 1995. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23: 1638-1652.
18. Moriya, K., Miura, N.N., Adachi, Y., and Ohno, N. 2002. Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/indomethacin administered mice. Biol. Pharm. Bull. 25: 816-822.
19. Moriya, K., Ohno, N., Miura, N.N., Adachi, Y., and Yadomae, T. 2002. Septic shock induced by microbial products and indomethacin. Drug Dev. Res. 55: 139-148.
20. Nameda, S., Saito, M., Miura, N.N., Adachi, Y., and Ohno, N. 2005. Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock. Biol. Pharm. Bull. 28: 1254-1258.
21. Okada, Y., Setoyama, H., Matsumoto, S., Imaoka, A., Nanno, M., Kawaguchi, M., and Umesaki, Y. 1994. Effects of fecal microorganisms and their chloroform-resistant variants derived from mice, rats, and humans on immunological and physiological characteristics of the intestines of exgermfree mice. Infect. Immun. 62: 5442-5446.
22. Ott, S.J., Musfeldt, M., Wenderoth, D.F., Hampe, J., Brant, O., Folsch, U.R., Timmis, K.N., and Schreiber, S. 2004. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
23. Riedemann, N.C., Guo, R.F., and Ward, P.A. 2003. The enigma of sepsis. J. Clin. Invest. 112: 460-467.
24. Sellon, R.K., Tonkonogy, S., Schultz, M., Dieleman, L.A., Grenther, W., Balish, E., Rennick, D.M., and Sartor, R.B. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66: 5224-5231.
25. Shapiro, N., Howell, M.D., Bates, D.W., Angus, D.C., Ngo, L., and Talmor, D. 2006. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann. Emerg. Med. 48: 583-590.
26. Simon, G.L., and Gorbach, S.L. 1984. Intestinal flora in health and disease. Gastroenterology 86: 174-193.
27. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., and Lochs, H. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
28. Takahashi, H., Ohno, N., Adachi, Y., and Yadomae, T. 2001. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan- administered mice. FEMS Immunol. Med. Microbiol. 31: 1-14.
29. Thiefin, G., and Beaugerie, L. 2005. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 72: 286-294.
30. Vane, J.R., Flower, R.J., and Botting, R.M. 1990. History of aspirin and its mechanism of action. Stroke 21: 12-23.
31. Yoshioka, S., Ohno, N., Miura, T., Adachi, Y., and Yadomae, T. 1998. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment. FEMS Immunol. Med. Microbiol. 21: 171-179.